183
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Role of Synbiotics (Prebiotics and Probiotics) as Dietary Supplements in Type 2 Diabetes Mellitus Induced Health Complications

, PhDORCID Icon, , MScORCID Icon & , PhDORCID Icon

References

  • Abbasi B, Abbasi H, Niroumand H. 2021. Synbiotic (FamiLact) administration in idiopathic male infertility enhances sperm quality, DNA integrity, and chromatin status: A triple-blinded randomized clinical trial. Int J Reprod Biomed. 19(3):235–244. doi: 10.18502/ijrm.v19i3.8571.
  • Abbasi B, Ghiasvand R, Mirlohi M. 2017. Kidney function improvement by soy milk containing Lactobacillus plantarum A7 in type 2 diabetic patients with nephropathy: a double-blinded randomized controlled trial. Iran J Kidney Dis. 11(1):36–43.
  • AbdelQadir YH, Hamdallah A, Sibaey EA, Hussein AS, Abdelaziz M, AbdelAzim A, Ragab KM, Helmy SK, Nourelden AZ. 2020. Efficacy of probiotic supplementation in patients with diabetic nephropathy: a systematic review and meta-analysis. Clin Nutr ESPEN. 40:57–67. doi: 10.1016/j.clnesp.2020.06.019.
  • Adiloglu AK, Ocal A, Can R, Duver H, Yavuz T, Aridogan BC. 2005. Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation. Saudi Med J. 26(7):1068–1074.
  • Akbarzadeh F, Homayouni A. 2012. Dairy probiotic foods and coronary heart disease: A review on mechanism of action. Probiotics. Rigobelo, E., editor. London: InTech; p. 121–128.
  • Al-Shamsi S, Regmi D, Govender RD. 2018. Chronic kidney disease in patients at high risk of cardiovascular disease in the United Arab Emirates: A population-based study. PLoS One. 13(6):e0199920. doi: 10.1371/journal.pone.0199920.
  • Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermúdez-Humarán LG, Smirnova N, Bergé M, Sulpice T, Lahtinen S, et al. 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 3(9):559–572. doi: 10.1002/emmm.201100159.
  • Amugsi DA, Dimbuene ZT, Mberu B, Muthuri S, Ezeh AC. 2017. Prevalence and time trends in overweight and obesity among urban women: an analysis of demographic and health surveys data from 24 African countries, 1991–2014. BMJ Open. 7(10):e017344. doi: 10.1136/bmjopen-2017-017344.
  • Archer AC, Muthukumar SP, Halami PM. 2021. Lactobacillus fermentum MCC2759 and MCC2760 alleviate inflammation and intestinal function in high-fat diet-fed and streptozotocin-induced diabetic rats. Probiot Antimicrob Proteins. 13(4):1068–1080. doi: 10.1007/s12602-021-09744-0.
  • Artasensi A, Pedretti A, Vistoli G, Fumagalli L. 2020. Type 2 diabetes mellitus: A review of multi-target drugs. Molecules. 25(8):1987. doi: 10.3390/molecules25081987.
  • Asemi Z, Khorrami-Rad A, Alizadeh S-A, Shakeri H, Esmaillzadeh A. 2014. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr. 33(2):198–203. doi: 10.1016/j.clnu.2013.05.015.
  • Aw W, Fukuda S. 2018. Understanding the role of the gut ecosystem in diabetes mellitus. J Diabetes Investig. 9(1):5–12. doi: 10.1111/jdi.12673.
  • Azam Z, Sapra L, Baghel K, Sinha N, Gupta RK, Soni V, Saini C, Mishra PK, Srivastava RK. 2023. Cissus quadrangularis (Hadjod) Inhibits RANKL-Induced Osteoclastogenesis and Augments Bone Health in an Estrogen-Deficient Preclinical Model of Osteoporosis Via Modulating the Host Osteoimmune System. Cells. 12(2):216. doi: 10.3390/cells12020216.
  • Azam Z, Sapra L, Bhardwaj A, Yadav S, Mishra PK, Shukla P, Sharma V, Srivastava RK. 2022. Crocin attenuates osteoclastogenesis and enhances bone health by skewing the immunoporotic “Treg-Th17” cell axis in post-menopausal osteoporotic mice model. Phytomedicine Plus. 2(3):100302. doi: 10.1016/j.phyplu.2022.100302.
  • Baghel K, Azam Z, Srivastava R, Gupta N, Kango N. 2023a. Withaferin-A attenuates diabetes mellitus induced male reproductive dysfunction mediated by ERα in brain and testes of Swiss albino mice. Sci Rep. 13(1):17625. doi: 10.1038/s41598-023-44904-y.
  • Baghel K, Azam Z, Srivastava R. 2024. Dietary restriction-induced alterations on estrogen receptor alpha expression in regulating fertility in male Coturnix coturnix japonica: relevance of Withania somnifera in modulation of inflammation and oxidative stress in testis. American Journal of Reproductive Immunology, 91(2): 1–15. doi: 10.1111/aji.13816.
  • Baghel K, Kumar M, Rashmi N. 2023b. Withania somnifera inhibits photorefractoriness which triggers neuronal apoptosis in both pre ‑ optic and paraventricular hypothalamic area of Coturnix coturnix japonica : involvement of oxidative stress induced p53 dependent Caspase ‑ 3 mediated low immu. Photochem Photobiol Sci. 22(9):2205–2218. doi: 10.1007/s43630-023-00442-0.
  • Baghel K, Niranjan MK, Srivastava R. 2020. Water and Food restriction decreases immunoreactivity of oestrogen receptor alpha and antioxidant activity in testes of sexually mature Coturnix coturnix japonica. J Anim Physiol Anim Nutr (Berl). 104(6):1738–1747. doi: 10.1111/jpn.13394.
  • Baghel K, Srivastava R. 2020a. Effect of estrogen and stress on estrogen receptor 1 in the HPG axis of immature male Gallus gallus domesticus: Involvement of anti-oxidant system. Theriogenology. 155:98–113. doi: 10.1016/j.theriogenology.2020.05.048.
  • Baghel K, Srivastava R. 2020b. Photoperiod dependent expression of estrogen receptor alpha in testes of Japanese quail: Involvement of Withania somnifera in apoptosis amelioration. Biochem Biophys Res Commun. 534:957–965. doi: 10.1016/j.bbrc.2020.10.064.
  • Baghel K, Srivastava R. 2021. Stress and steroid interaction modulates expression of estrogen receptor alpha in the brain, pituitary, and testes of immature Gallus gallus domesticus. Stress. 24(6):931–944. doi: 10.1080/10253890.2021.1965119.
  • Bai J, Wan Z, Zhang Y, Wang T, Xue Y, Peng Q. 2022. Composition and diversity of gut microbiota in diabetic retinopathy. Front Microbiol. 13:926926. doi: 10.3389/fmicb.2022.926926.
  • Balasopoulou A, Κokkinos P, Pagoulatos D, Plotas P, Makri OE, Georgakopoulos CD, Vantarakis A, Li Y, Liu JJ, Qi P, et al. 2017. Symposium Recent advances and challenges in the management of retinoblastoma Globe ‑ saving Treatments. BMC Ophthalmol. 17(1):1. doi: 10.4103/ijo.IJO.
  • Bander ZA, Nitert MD, Mousa A, Naderpoor N. 2020. The gut microbiota and inflammation: An overview. Int J Environ Res Public Health. 17(20):7618. doi: 10.3390/ijerph17207618.
  • Barczynska R, Kapusniak J, Litwin M, Slizewska K, Szalecki M. 2016. Dextrins from maize starch as substances activating the growth of bacteroidetes and actinobacteria simultaneously inhibiting the growth of firmicutes, responsible for the occurrence of obesity. Plant Foods Hum Nutr. 71(2):190–196. doi: 10.1007/s11130-016-0542-9.
  • Batzias K, Antonopoulos AS, Oikonomou E, Siasos G, Bletsa E, Stampouloglou PK, Mistakidi C-V, Noutsou M, Katsiki N, Karopoulos P, et al. 2018. Effects of newer antidiabetic drugs on endothelial function and arterial stiffness: a systematic review and meta-analysis. J Diabetes Res. 2018:1232510–1232583. doi: 10.1155/2018/1232583.
  • Baynest HW. 2015. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. J Diabetes Metab. 06(05):1–9. doi: 10.4172/2155-6156.1000541.
  • Beli E, Yan Y, Moldovan L, Vieira CP, Gao R, Duan Y, Prasad R, Bhatwadekar A, White FA, Townsend SD, et al. 2018. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/db mice. Diabetes. 67(9):1867–1879. doi: 10.2337/db18-0158.
  • Birkeland E, Gharagozlian S, Birkeland KI, Valeur J, Måge I, Rud I, Aas A-M. 2020. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial. Eur J Nutr. 59(7):3325–3338. doi: 10.1007/s00394-020-02282-5.
  • Brunkwall L, Orho-Melander M. 2017. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia. 60(6):943–951. doi: 10.1007/s00125-017-4278-3.
  • Budzyński J, Wiśniewska J, Ciecierski M, Kędzia A. 2015. Association between bacterial infection and peripheral vascular disease: a review. Int J Angiol. 25(1):3–13. doi: 10.1055/s-0035-1547385.
  • Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes. 57(6):1470–1481. doi: 10.2337/db07-1403.
  • Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM. 2005. Involvement of endogenous glucagon-like peptide-1 (7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol. 185(3):457–465. doi: 10.1677/joe.1.06100.
  • Cani PD, Everard A. 2016. Talking microbes: when gut bacteria interact with diet and host organs. Mol Nutr Food Res. 60(1):58–66. doi: 10.1002/mnfr.201500406.
  • Celik A, Forde R, Racaru S, Forbes A, Sturt J. 2022. The Impact of Type 2 Diabetes on Women’s Health and Well-being During Their Reproductive Years: A Mixed-methods Systematic Review. Curr Diabetes Rev. 18(2):e011821190403. doi: 10.2174/1573399817666210118144743.
  • Chawla A, Chawla R, Jaggi S. 2016. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Ind J Endocrinol Metab. 20(4):546–551. doi: 10.4103/2230-8210.183480.
  • Collins FL, Rios-Arce ND, Schepper JD, Parameswaran N, McCabe LR. 2017. The potential of probiotics as a therapy for osteoporosis. Microbiol Spectr. 5(4):4–5. doi: 10.1128/microbiolspec.BAD-0015-2016.
  • Covasa M, Stephens RW, Toderean R, Cobuz C. 2019. Intestinal sensing by gut microbiota: targeting gut peptides. Front Endocrinol (Lausanne). 10:82. doi: 10.3389/fendo.2019.00082.
  • Cozzolino M, Vitagliano A, Pellegrini L, Chiurazzi M, Andriasani A, Ambrosini G, Garrido N. 2020. Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis. Eur J Nutr. 59(7):2841–2856. doi: 10.1007/s00394-020-02233-0.
  • Cunningham AL, Stephens JW, Harris DA. 2021. Gut microbiota influence in type 2 diabetes mellitus (T2DM). Gut Pathog. 13(1):50. doi: 10.1186/s13099-021-00446-0.
  • Dardmeh F, Alipour H, Gazerani P, van der Horst G, Brandsborg E, Nielsen HI. 2017. Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model. PLoS One. 12(10):e0185964. doi: 10.1371/journal.pone.0185964.
  • Dash SC, Agarwal SK, Panigrahi A, Mishra J, Dash D. 2018. Diabetes, hypertension and kidney disease combination “DHKD syndrome” is common in India. J Assoc Physicians India. 66(3):30–33.
  • Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. 2019. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 8(3):92. doi: 10.3390/foods8030092.
  • de Groot P, Nikolic T, Pellegrini S, Sordi V, Imangaliyev S, Rampanelli E, Hanssen N, Attaye I, Bakker G, Duinkerken G, et al. 2021. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. Gut. 70(1):92–105. doi: 10.1136/gutjnl-2020-322630.
  • Delzenne NM, Cani PD, Neyrinck AM. 2007. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr. 137(11 Suppl):2547S–2551S. doi: 10.1093/jn/137.11.2547S.
  • Denis GV, Obin MS. 2013. ‘Metabolically healthy obesity’: origins and implications. Mol Aspects Med. 34(1):59–70. doi: 10.1016/j.mam.2012.10.004.
  • Deshmukh CD, Jain A, Nahata B. 2015. Diabetes mellitus: a review. Int J Pure Appl Biosci. 3(3):224–230.
  • Dong B, Shi Z, Dong Y, Chen J, Wu Z-X, Wu W, Chen Z-S, Han C. 2022. Quercetin ameliorates oxidative stress‑induced cell apoptosis of seminal vesicles via activating Nrf2 in type 1 diabetic rats. Biomed Pharmacother. 151:113108. doi: 10.1016/j.biopha.2022.113108.
  • Eaimworawuthikul S, Tunapong W, Chunchai T, Yasom S, Wanchai K, Suntornsaratoon P, Charoenphandhu N, Thiennimitr P, Chattipakorn N, Chattipakorn SC. 2019. Effects of probiotics, prebiotics or synbiotics on jawbone in obese-insulin resistant rats. Eur J Nutr. 59(4):1453–1462. doi: 10.1007/s00394-018-1829-4.
  • Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. 2012. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 28(5):539–543. doi: 10.1016/j.nut.2011.08.013.
  • Emoto T, Yamashita T, Kobayashi T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, et al. 2017. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels. 32(1):39–46. doi: 10.1007/s00380-016-0841-y.
  • Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, Islam N, Bravo RF, Aleckovic-Halilovic M, Zou H, et al. 2016. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 4(5):e307–e319. doi: 10.1016/S2214-109X(16)00071-1.
  • Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, Poustchi H. 2014. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 112(3):438–445. doi: 10.1017/S0007114514000919.
  • Ferrannini E, Gastaldelli A, Iozzo P. 2011. Pathophysiology of Prediabetes. Med Clin North Am. 95(2):327–339. doi: 10.1016/j.mcna.2010.11.005.
  • Fijan S, Frauwallner A, Langerholc T, Krebs B, ter Haar Née Younes JA, Heschl A, Mičetić Turk D, Rogelj I. 2019. Efficacy of using probiotics with antagonistic activity against pathogens of wound infections: an integrative review of literature. Biomed Res Int. 2019:7585486–7585421. doi: 10.1155/2019/7585486.
  • Firouzi S, Majid HA, Ismail A, Kamaruddin NA, Barakatun-Nisak M-Y. 2017. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. Eur J Nutr. 56(4):1535–1550. doi: 10.1007/s00394-016-1199-8.
  • Fukuuchi F, Hida M, Aiba Y, Koga Y, Endoh M, Kurokawa K, Sakai H. 2002. Intestinal bacteria-derived putrefactants in chronic renal failure. Clin Exp Nephrol. 6(2):99–104. doi: 10.1007/s101570200016.
  • Ghafouri A, Zarrati M, Shidfar F, Heydari I, Shokouhi Shoormasti R, Eslami O. 2019. Effect of synbiotic bread containing lactic acid on glycemic indicators, biomarkers of antioxidant status and inflammation in patients with type 2 diabetes: a randomized controlled trial. Diabetol Metab Syndr. 11(1):103. doi: 10.1186/s13098-019-0496-9.
  • Gibson GR,Hutkins R,Sanders ME,Prescott SL,Reimer RA,Salminen SJ,Scott K,Stanton C,Swanson KS,Cani PD, et al. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 14(8):491–502. doi:10.1038/nrgastro.2017.75.
  • Gibson GR,Scott KP,Rastall RA,Tuohy KM,Hotchkiss A,Dubert-Ferrandon A,Gareau M,Murphy EF,Saulnier D,Loh G, et al. 2010. Dietary prebiotics: current status and new definition. Food Science & Technology Bulletin: Functional Foods. 7(1):1–19. doi:10.1616/1476-2137.15880.
  • Gourgari E, Wilhelm EE, Hassanzadeh H, Aroda VR, Shoulson I. 2017. A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. J Diabetes Complicat. 31(12):1719–1727. doi: 10.1016/j.jdiacomp.2017.08.005.
  • Gupta V, Srivastava R. 2022. 2.45 GHz microwave radiation induced oxidative stress: Role of inflammatory cytokines in regulating male fertility through estrogen receptor alpha in Gallus gallus domesticus. Biochem Biophys Res Commun. 629:61–70. doi: 10.1016/j.bbrc.2022.09.009.
  • Haghighat N, Mohammadshahi M, Shayanpour S, Haghighizadeh MH. 2019. Effect of synbiotic and probiotic supplementation on serum levels of endothelial cell adhesion molecules in hemodialysis patients: A randomized control study. Probiotics Antimicrob Proteins. 11(4):1210–1218. doi: 10.1007/s12602-018-9477-9.
  • Han J-L, Lin H-L. 2014. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. World J Gastroenterol. 20(47):17737–17745. doi: 10.3748/wjg.v20.i47.17737.
  • He Z, Yin G, Li QQ, Zeng Q, Duan J. 2021. Diabetes mellitus causes male reproductive dysfunction: A review of the evidence and mechanisms. In Vivo. 35(5):2503–2511. doi: 10.21873/invivo.12531.
  • Ho J, Nicolucci AC, Virtanen H, Schick A, Meddings J, Reimer RA, Huang C. 2019. Effect of prebiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes. J Clin Endocrinol Metab. 104(10):4427–4440. doi: 10.1210/jc.2019-00481.
  • Hoffmann A, Kleniewska P, Pawliczak R. 2021. Antioxidative activity of probiotics. Arch Med Sci. 17(3):792–804. doi: 10.5114/aoms.2019.89894.
  • Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. 2011. Understanding the role of gut microbiome–host metabolic signal disruption in health and disease. Trends Microbiol. 19(7):349–359. doi: 10.1016/j.tim.2011.05.006.
  • Homme RP, George AK, Stanisic DN, Malonee C, Molnar J, Smolenkova I, Sandhu HA, Si Tyagi SC, Singh M. 2020. Effects of probiotic on the development of diabetic retinopathy. Investigat Ophthalmol Visual Sci. 61(7):4961.
  • Hu F, Niu Y, Xu X, Hu Q, Su Q, Zhang H. 2020. Resistant dextrin improves high-fat-high-fructose diet induced insulin resistance. Nutr Metab (Lond). 17(1):36. doi: 10.1186/s12986-020-00450-2.
  • Huang Y, Yang B, Li W. 2016. Defining the normal core microbiome of conjunctival microbial communities. Clinical Microbiol Infect. 22(7):643-e7–643.e12. doi: 10.1016/j.cmi.2016.04.008.
  • Hume MP, Nicolucci AC, Reimer RA. 2017. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am J Clin Nutr. 105(4):790–799. doi: 10.3945/ajcn.116.140947.
  • Huseini HF, Rahimzadeh G, Fazeli MR, Mehrazma M, Salehi M. 2012. Evaluation of wound healing activities of kefir products. Burns. 38(5):719–723. doi: 10.1016/j.burns.2011.12.005.
  • Hussain S, Habib A, Najmi AK. 2019. Limited knowledge of chronic kidney disease among type 2 diabetes mellitus patients in India. Int J Environ Res Public Health. 16(8):1443. doi: 10.3390/ijerph16081443.
  • Hussain S, Jamali MC, Habib A, Hussain MS, Akhtar M, Najmi AK. 2021. Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers. Clinical Epidemiology and Global Health. 9:2–6. doi: 10.1016/j.cegh.2020.05.016.
  • Iatcu CO, Steen A, Covasa M. 2022. Gut microbiota and complications of type-2 diabetes. Nutrients. 14(1):166–196. doi: 10.3390/nu14010166.
  • IDF. 2017. Eighth edition 2017. In IDF Diabetes Atlas, 8th edition. https://www.idf.org/aboutdiabetes/type-2-diabetes.html.
  • Jackuliak P, Payer J. 2017. Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2017:2846080–2846010. doi: 10.1155/2017/2846080.
  • Jiang H,Zhang Yan,Xu D,Wang Q. 2021. Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study. Clinical Laboratory Analysis. 35(4). e23650. doi: 10.1002/jcla.23650.
  • Jiang H, Cai M, Shen B, Wang Q, Zhang T, Zhou X. 2022. Synbiotics and gut microbiota: New perspectives in the treatment of type 2 diabetes mellitus. Foods. 11(16):2438. doi: 10.3390/foods11162438.
  • Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, Zhou Y, Lin Q, Zhou H, Jiang J, et al. 2017. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep. 7(1):2870. doi: 10.1038/s41598-017-02989-2.
  • Joung JY, Lim W, Seo YJ, Ham J, Oh NS, Kim SH. 2022. A synbiotic combination of Lactobacillus gasseri 505 and Cudrania tricuspidata leaf extract prevents stress-induced testicular dysfunction in mice. Front Endocrinol (Lausanne). 13:835033. doi: 10.3389/fendo.2022.835033.
  • Kanazawa A, Aida M, Yoshida Y, Kaga H, Katahira T, Suzuki L, Tamaki S, Sato J, Goto H, Azuma K, et al. 2021. Effects of synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes mellitus: a randomized controlled study. Nutrients. 13(2):558. doi: 10.3390/nu13020558.
  • Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A, Vaziri ND. 2018. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol. 50(8):1453–1466. doi: 10.1007/s11255-018-1873-2.
  • Karadurmus N, Sahin M, Tasci C, Naharci I, Ozturk C, Ilbasmis S, Dulkadir Z, Sen A, Saglam K. 2010. Potential benefits of hyperbaric oxygen therapy on atherosclerosis and glycaemic control in patients with diabetic foot. Endokrynol Pol. 61(3):275–279.
  • Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, Bäckhed F, Nielsen J. 2012. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 3(1):1245. doi: 10.1038/ncomms2266.
  • Kellow NJ, Coughlan MT, Savige GS, Reid CM. 2014. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial. BMC Endocr Disord. 14(1):55. doi: 10.1186/1472-6823-14-55.
  • Kesika P, Sivamaruthi BS, Chaiyasut C. 2019. Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials. Biomed Res Int. 2019:1531567–1531511. doi: 10.1155/2019/1531567.
  • Khalili L, Alipour B, Jafar-Abadi MA, Faraji I, Hassanalilou T, Abbasi MM, Vaghef-Mehrabany E, Sani MA, Department of Nutrition, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 2019. The effects of Lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Ibj. 23(1):68–77. doi: 10.29252/ibj.23.1.68.
  • Khan A,Kango N,Srivastava R. 2024. Impact of Dietary Probiotics on the Immune and Reproductive Physiology of Pubertal Male Japanese Quail (Coturnix coturnix japonica) Administered at the Onset of Pre-Puberty. Probiotics Antimicrob Proteins. doi: 10.1007/s12602-023-10209-9. 38170389
  • Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore ME, Marco ML, Martin RJ, et al. 2016. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. Am J Physiol Renal Physiol. 310(9):F857–F871. doi: 10.1152/ajprenal.00513.2015.
  • Kim D-E, Kim J-K, Han S-K, Jang S-E, Han MJ, Kim D-H. 2019. Lactobacillus plantarum NK3 and Bifidobacterium longum NK49 alleviate bacterial vaginosis and osteoporosis in mice by suppressing NF-κ B-Linked TNF-α expression. J Med Food. 22(10):1022–1031. doi: 10.1089/jmf.2019.4419.
  • Klancic T, Laforest-Lapointe I, Choo A, Nettleton JE, Chleilat F, Noye Tuplin EW, Alukic E, Cho NA, Nicolucci AC, Arrieta M-C, et al. 2020. Prebiotic oligofructose prevents antibiotic‐induced obesity risk and improves metabolic and gut microbiota profiles in rat dams and offspring. Mol Nutr Food Res. 64(16):e2000288. doi: 10.1002/mnfr.202000288.
  • Kleniewska P, Pawliczak R. 2017. Influence of synbiotics on selected oxidative stress parameters. Oxid Med Cell Longev. 2017:9315375–9315378. doi: 10.1155/2017/9315375.
  • Kobyliak N, Falalyeyeva T, Mykhalchyshyn G, Kyriienko D, Komissarenko I. 2018. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial. Diabetes Metab Syndr. 12(5):617–624. doi: 10.1016/j.dsx.2018.04.015.
  • Kocsis T, Molnár B, Németh D, Hegyi P, Szakács Z, Bálint A, Garami A, Soós A, Márta K, Solymár M. 2020. Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials. Sci Rep. 10(1):11787. doi: 10.1038/s41598-020-68440-1.
  • Kruger MC, Fear A, Chua W-H, Plimmer GG, Schollum LM. 2009. The effect of Lactobacillus rhamnosus HN001 on mineral absorption and bone health in growing male and ovariectomised female rats. Dairy Sci Technol. 89(3-4):219–231. doi: 10.1051/dst/2009012.
  • Krumbeck JA, Maldonado-Gomez MX, Ramer-Tait AE, Hutkins RW. 2016. Prebiotics and synbiotics: dietary strategies for improving gut health. Curr Opin Gastroenterol. 32(2):110–119. doi: 10.1097/MOG.0000000000000249.
  • Lam VY, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. 2012. Intestinal microbiota determine severity of myocardial infarction in rats. Faseb J. 26(4):1727–1735. doi: 10.1096/fj.11-197921.
  • Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. 2018. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 6(1):69–80. doi: 10.1016/S2213-8587(17)30186-9.
  • Lawenius L, Gustafsson KL, Wu J, Nilsson KH, Movérare-Skrtic S, Schott EM, Soto-Girón MJ, Toledo GV, Sjögren K, Ohlsson C. 2022. Development of a synbiotic that protects against ovariectomy-induced trabecular bone loss. Am J Physiol Endocrinol Metab. 322(4):E344–E354. doi: 10.1152/ajpendo.00366.2021.
  • Lee CB, Chae SU, Jo SJ, Jerng UM, Bae SK. 2021. The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus. Int J Mol Sci. 22(7):3566. doi: 10.3390/ijms22073566.
  • Li H-Y, Zhou D-D, Gan R-Y, Huang S-Y, Zhao C-N, Shang A, Xu X-Y, Li H-B. 2021. Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review. Nutrients. 13(9):3211. doi: 10.3390/nu13093211.
  • Li Q, Xu K, Du TAO, Zhu P, Verma A. 2018. Recombinant probiotics expressing angiotensin-(1-7) improves glucose metabolism and diabetes-induced renal and retinal injury. Diabetes. 67(Supplement_1) doi: 10.2337/db18-33-LB.
  • Li Y, Liu M, Liu H, Wei X, Su X, Li M, Yuan J. 2020. Oral supplements of combined Bacillus licheniformis Zhengchangsheng® and xylooligosaccharides improve high-fat diet-induced obesity and modulate the gut microbiota in rats. Biomed Res Int. 2020:9067821. doi: 10.1155/2020/9067821.
  • Liber A, Szajewska H. 2014. Effect of oligofructose supplementation on body weight in overweight and obese children: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 112(12):2068–2074. doi: 10.1017/S0007114514003110.
  • Lindsay KL, Kennelly M, Culliton M, Smith T, Maguire OC, Shanahan F, Brennan L, McAuliffe FM. 2014. Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study). Am J Clin Nutr. 99(6):1432–1439. doi: 10.3945/ajcn.113.079723.
  • Liong M-T, Dunshea FR, Shah NP. 2007. Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high-and low-fat diets. Br J Nutr. 98(4):736–744. doi: 10.1017/S0007114507747803.
  • Liu W, Luo Z, Zhou J, Sun B. 2022. Gut microbiota and antidiabetic drugs: Perspectives of personalized treatment in type 2 diabetes mellitus. Front Cell Infect Microbiol. 12:853771. doi: 10.3389/fcimb.2022.853771.
  • Liu X, Chen F, Liu L, Zhang Q. 2023. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr Disord. 23(1):1–12. doi: 10.1186/s12902-022-01260-8.
  • Lu ZX, Walker KZ, Muir JG, O’Dea K. 2004. Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin Nutr. 58(4):621–628. doi: 10.1038/sj.ejcn.1601857.
  • Lundy SD, Sangwan N, Parekh NV, Selvam MKP, Gupta S, McCaffrey P, Bessoff K, Vala A, Agarwal A, Sabanegh ES, et al. 2021. Functional and taxonomic dysbiosis of the gut, urine, and semen microbiomes in male infertility. Eur Urol. 79(6):826–836. doi: 10.1016/j.eururo.2021.01.014.
  • Ma RCW. 2016. Genetics of cardiovascular and renal complications in diabetes. J Diabetes Investig. 7(2):139–154. doi: 10.1111/jdi.12391.
  • Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. 2019. Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study. PLoS One. 14(11):e0225168. doi: 10.1371/journal.pone.0225168.
  • Madjd A, Taylor MA, Mousavi N, Delavari A, Malekzadeh R, Macdonald IA, Farshchi HR. 2016. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: a randomized controlled trial. Am J Clin Nutr. 103(2):323–329. doi: 10.3945/ajcn.115.120170.
  • Mafi A, Namazi G, Soleimani A, Bahmani F, Aghadavod E, Asemi Z. 2018. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food Funct. 9(9):4763–4770. doi: 10.1039/c8fo00888d.
  • Mahboobi S, Rahimi F, Jafarnejad S. 2018. Effects of prebiotic and synbiotic supplementation on glycaemia and lipid profile in type 2 diabetes: a meta-analysis of randomized controlled trials. Adv Pharm Bull. 8(4):565–574. doi: 10.15171/apb.2018.065.
  • Mahmoodpoor F, Saadat YR, Barzegari A, Ardalan M, Vahed SZ. 2017. The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother. 93:412–419. doi: 10.1016/j.biopha.2017.06.066.
  • Markowiak-Kopeć P, Śliżewska K. 2020. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 12(4):1107. doi: 10.3390/nu12041107.
  • Mazruei Arani N, Emam-Djomeh Z, Tavakolipour H, Sharafati-Chaleshtori R, Soleimani A, Asemi Z. 2019. The effects of probiotic honey consumption on metabolic status in patients with diabetic nephropathy: a randomized, double-blind, controlled trial. Probiotics Antimicrob Proteins. 11(4):1195–1201. doi: 10.1007/s12602-018-9468-x.
  • McMullan CJ, Heerspink HJL, Parving H-H, Dwyer JP, Forman JP, de Zeeuw D. 2014. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis. 64(5):714–722. doi: 10.1053/j.ajkd.2014.06.008.
  • Miraghajani M, Zaghian N, Mirlohi M, Feizi A, Ghiasvand R. 2017. The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients: a randomized controlled clinical trial. J Ren Nutr. 27(5):317–324. doi: 10.1053/j.jrn.2017.04.004.
  • Miranda-Díaz AG, Pazarín-Villaseñor L, Yanowsky-Escatell FG, Andrade-Sierra J. 2016. Oxidative stress in diabetic nephropathy with early chronic kidney disease. J Diabetes Res. 2016:7047238–7047237. doi: 10.1155/2016/7047238.
  • Mirmiranpour H, Huseini HF, Derakhshanian H, Khodaii Z, Tavakoli-Far B. 2020. Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic control and antioxidant status in people with type 2 diabetes; a randomized, double-blind, placebo-controlled study. J Diabetes Metab Disord. 19(1):53–60. doi: 10.1007/s40200-019-00474-3.
  • Mishra A,Chakravarty I,Mandavgane S. 2021. Current trends in non-dairy based synbiotics. Crit. Rev. Biotechnol. 41(6):935–952. doi: 10.1080/07388551.2021.1898329.
  • Mistry RH, Liu F, Borewicz K, Lohuis MAM, Smidt H, Verkade HJ, Tietge UJF. 2020. Long‐term β‐galacto‐oligosaccharides supplementation decreases the development of obesity and insulin resistance in mice fed a western‐type diet. Mol Nutr Food Res. 64(12):e1900922. doi: 10.1002/mnfr.201900922.
  • Mofid V, Izadi A, Mojtahedi SY, Khedmat L. 2020. Therapeutic and nutritional effects of synbiotic yogurts in children and adults: a clinical review. Probiotics Antimicrob Proteins. 12(3):851–859. doi: 10.1007/s12602-019-09594-x.
  • Mohan V, Khunti K, Chan SP, Filho FF, Tran NQ, Ramaiya K, Joshi S, Mithal A, Mbaye MN, Nicodemus NA, et al. 2020. Management of type 2 diabetes in developing countries: balancing optimal glycaemic control and outcomes with affordability and accessibility to treatment. Diabetes Ther. 11(1):15–35. doi: 10.1007/s13300-019-00733-9.
  • Mohseni S, Bayani M, Bahmani F, Tajabadi‐Ebrahimi M, Bayani MA, Jafari P, Asemi Z. 2018. The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double‐blind, placebo‐controlled trial. Diabetes Metab Res Rev. 34(3):e2970. doi: 10.1002/dmrr.2970.
  • Muscogiuri G, Barrea L, Caprio M, Ceriani F, Chavez AO, El Ghoch M, Frias-Toral E, Mehta RJ, Mendez V, Paschou SA, et al. 2022. Nutritional guidelines for the management of insulin resistance. Crit Rev Food Sci Nutr. 62(25):6947–6960. doi: 10.1080/10408398.2021.1908223.
  • Nabhani Z, Clark CCT, Goudarzi N, Hariri Far A, Razmpoosh E. 2022. The effect of synbiotic supplementation on atherogenic indices, hs-CRP, and malondialdehyde, as major CVD-related parameters, in women with gestational diabetes mellitus: a secondary data-analysis of a randomized double-blind, placebo-controlled study. Diabetol Metab Syndr. 14(1):87. doi: 10.1186/s13098-022-00858-1.
  • Naderpoor N, Mousa A, Gomez-Arango LF, Barrett HL, Dekker Nitert M, de Courten B. 2019. Faecal microbiota are related to insulin sensitivity and secretion in overweight or obese adults. J Clin Med. 8(4):452. doi: 10.3390/jcm8040452.
  • Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K, Yoshida M. 2011. Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant. 26(3):1094–1098. doi: 10.1093/ndt/gfq624.
  • Naseri K, Saadati S, Yari Z, Asbaghi O, Hezaveh ZS, Mafi D, Hoseinian P, Ashtary-Larky D, Hekmatdoost A, de Courten B. 2022. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res. 182:106288. doi: 10.1016/j.phrs.2022.106288.
  • Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA. 2017. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology. 153(3):711–722. doi: 10.1053/j.gastro.2017.05.055.
  • Obuchowska A, Gorczyca K, Standyło A, Obuchowska K, Kimber-Trojnar Ż, Wierzchowska-Opoka M, Leszczyńska-Gorzelak B. 2022. Effects of probiotic supplementation during pregnancy on the future maternal risk of metabolic syndrome. Int J Mol Sci. 23(15):8253. doi: 10.3390/ijms23158253.
  • Oh YJ, Kim HJ, Kim TS, Yeo IH, Ji GE. 2019. Effects of Lactobacillus plantarum PMO 08 alone and combined with chia seeds on metabolic syndrome and parameters related to gut health in high-fat diet-induced obese mice. J Med Food. 22(12):1199–1207. doi: 10.1089/jmf.2018.4349.
  • Ohashi Y, Ushida K. 2009. Health‐beneficial effects of probiotics: Its mode of action. Anim Sci J. 80(4):361–371. doi: 10.1111/j.1740-0929.2009.00645.x.
  • Olas B. 2020. Probiotics, prebiotics and synbiotics—a promising strategy in prevention and treatment of cardiovascular diseases? Int J Mol Sci. 21(24):9737. doi: 10.3390/ijms21249737.
  • Ostadrahimi A, Taghizadeh A, Mobasseri M, Farrin N, Payahoo L, Gheshlaghi ZB, Vahedjabbari M. 2015. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health. 44(2):228.
  • Ozkan J, Willcox M, Wemheuer B, Wilcsek G, Coroneo M, Thomas T. 2019. Biogeography of the human ocular microbiota. Ocul Surf. 17(1):111–118. doi: 10.1016/j.jtos.2018.11.005.
  • Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. 2018. Complications of diabetes 2017. J Diabetes Res. 2018:3086167–3086164. doi: 10.1155/2018/3086167.
  • Papatheodorou K, Papanas N, Banach M, Papazoglou D, Edmonds M. 2016. Complications of diabetes 2016. J Diabetes Res. 2016:6989453–6989453. doi: 10.1155/2016/6989453.
  • Picke A-K, Campbell G, Napoli N, Hofbauer LC, Rauner M. 2019. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 8(3):R55–R70. doi: 10.1530/EC-18-0456.
  • Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. 2014. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One. 9(1):e84877. doi: 10.1371/journal.pone.0084877.
  • Rahimiyan-Heravan M, Roshangar L, Karimi P, Sefidgari-Abrasi S, Morshedi M, Saghafi-Asl M, Bavafa-Valenlia K. 2020. The potential therapeutic effects of Lactobacillus plantarum and inulin on serum and testicular reproductive markers in diabetic male rats. Diabetol Metab Syndr. 12(1):53. doi: 10.1186/s13098-020-00560-0.
  • Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. 2016. Role of the gut microbiome in uremia: a potential therapeutic target. Am J Kidney Dis. 67(3):483–498. doi: 10.1053/j.ajkd.2015.09.027.
  • Rangé H, Labreuche J, Louedec L, Rondeau P, Planesse C, Sebbag U, Bourdon E, Michel J-B, Bouchard P, Meilhac O. 2014. Periodontal bacteria in human carotid atherothrombosis as a potential trigger for neutrophil activation. Atherosclerosis. 236(2):448–455. doi: 10.1016/j.atherosclerosis.2014.07.034.
  • Ray PD, Huang BW, Tsuji Y. 2012. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. In Cell Signal. 24(5):981–990. doi: 10.1016/j.cellsig.2012.01.008.
  • Raygan F, Rezavandi Z, Bahmani F, Ostadmohammadi V, Mansournia MA, Tajabadi-Ebrahimi M, Borzabadi S, Asemi Z. 2018. The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease. Diabetol Metab Syndr. 10(1):51. doi: 10.1186/s13098-018-0353-2.
  • Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, Group, U. S. 2006. Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes. 55(6):1832–1839. doi: 10.2337/db05-1620.
  • Rittiphairoj T, Pongpirul K, Janchot K, Mueller NT, Li T. 2021. Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and Meta-analysis. Adv Nutr. 12(3):722–734. doi: 10.1093/advances/nmaa133.
  • Rowe M, Veerus L, Trosvik P, Buckling A, Pizzari T. 2020. The reproductive microbiome: an emerging driver of sexual selection, sexual conflict, mating systems, and reproductive isolation. Trends Ecol Evol. 35(3):220–234. doi: 10.1016/j.tree.2019.11.004.
  • Sabico S, Al-Mashharawi A, Al-Daghri NM, Wani K, Amer OE, Hussain DS, Ansari MGA, Masoud MS, Alokail MS, McTernan PG. 2019. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 38(4):1561–1569. doi: 10.1016/j.clnu.2018.08.009.
  • Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R. 2020. Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 162:108086. doi: 10.1016/j.diabres.2020.108086.
  • Sapra L, Dar HY, Bhardwaj A, Pandey A, Kumari S, Azam Z, Upmanyu V, Anwar A, Shukla P, Mishra PK, et al. 2021. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice. Sci Rep. 11(1):1807. doi: 10.1038/s41598-020-80536-2.
  • Sarfraz F,Farooq U,Shafi A,Hayat Z,Akram K,Rehman H. 2019. Hypolipidaemic effects of synbiotic yoghurt in rabbits. Int J of Dairy Tech. 72(4):545–550. doi:10.1111/1471-0307.12618.
  • Sawacha Z, Guarneri G, Avogaro A, Cobelli C. 2010. A new classification of diabetic gait pattern based on cluster analysis of biomechanical data. Los Angeles (CA): SAGE Publications Sage CA.
  • Scholz-Ahrens KE, Adolphi B, Rochat F, Barclay DV, de Vrese M, Açil Y, Schrezenmeir J. 2016. Effects of probiotics, prebiotics, and synbiotics on mineral metabolism in ovariectomized rats—impact of bacterial mass, intestinal absorptive area and reduction of bone turn-over. Nfs J. 3:41–50. doi: 10.1016/j.nfs.2016.03.001.
  • Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR, III, Aguilar RB. 2016. The time is right for a new classification system for diabetes: rationale and implications of the β-cell–centric classification schema. Diabetes Care. 39(8):e129–e130. doi: 10.2337/dc15-1585.
  • Sharma S, Tripathi P. 2019. Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem. 63:101–108. doi: 10.1016/j.jnutbio.2018.10.003.
  • Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. 2020. Diabetes and global ageing among 65–99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 162:108078. doi: 10.1016/j.diabres.2020.108078.
  • Sudha MR, Ahire JJ, Jayanthi N, Tripathi A, Nanal S. 2019. Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: A 12-week double blind, randomised, placebo-controlled study. Benef Microbes. 10(8):855–866. doi: 10.3920/BM2019.0052.
  • Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. 2022. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 183:109119. doi: 10.1016/j.diabres.2021.109119.
  • Sun Z, Sun X, Li J, Li Z, Hu Q, Li L, Hao X, Song M, Li C. 2020. Using probiotics for type 2 diabetes mellitus intervention: advances, questions, and potential. Crit Rev Food Sci Nutr. 60(4):670–683. doi: 10.1080/10408398.2018.1547268.
  • Thiennimitr P, Yasom S, Tunapong W, Chunchai T, Wanchai K, Pongchaidecha A, Lungkaphin A, Sirilun S, Chaiyasut C, Chattipakorn N, et al. 2018. Lactobacillus paracasei HII01, xylooligosaccharides, and synbiotics reduce gut disturbance in obese rats. Nutrition. 54:40–47. doi: 10.1016/j.nut.2018.03.005.
  • Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, et al. 2009. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10(3):167–177. doi: 10.1016/j.cmet.2009.08.001.
  • Tonucci LB, Dos Santos KMO, de Oliveira LL, Ribeiro SMR, Martino HSD. 2017. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr. 36(1):85–92. doi: 10.1016/j.clnu.2015.11.011.
  • Tsai Y-L, Lin T-L, Chang C-J, Wu T-R, Lai W-F, Lu C-C, Lai H-C. 2019. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci. 26(1):3. doi: 10.1186/s12929-018-0493-6.
  • Van de Wiele T, Van Praet JT, Marzorati M, Drennan MB, Elewaut D. 2016. How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol. 12(7):398–411. doi: 10.1038/nrrheum.2016.85.
  • Vancamelbeke M, Vermeire S. 2017. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 11(9):821–834. doi: 10.1080/17474124.2017.1343143.
  • Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, Lernmark Å, Hagopian WA, Rewers MJ, She J-X, et al. 2018. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 562(7728):589–594. doi: 10.1038/s41586-018-0620-2.
  • Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. 2013. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am J Nephrol. 38(2):99–103. doi: 10.1159/000353764.
  • Velayati A, Kareem I, Sedaghat M, Sohrab G, Nikpayam O, Hedayati M, Abhari K, Hejazi E. 2023. Does symbiotic supplementation which contains Bacillus coagulans, Lactobacillus rhamnosus, Lactobacillus acidophilus and fructooligosaccharide has favourite effects in patients with type-2 diabetes? A randomised, double-blind, placebo-controlled trial. Arch Physiol Biochem. 129(6):1211–1218. doi: 10.1080/13813455.2021.1928225.
  • Verma A, Xu K, Du T, Zhu P, Liang Z, Liao S, Zhang J, Raizada MK, Grant MB, Li Q. 2019. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol Ther Methods Clin Dev. 14:161–170. doi: 10.1016/j.omtm.2019.06.007.
  • Vieira-Potter VJ, Karamichos D, Lee DJ. 2016. Ocular complications of diabetes and therapeutic approaches. Biomed Res Int. 2016:3801570–3801514. doi: 10.1155/2016/3801570.
  • Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P. 2010. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol. 10(1):4. doi: 10.1186/1471-2180-10-4.
  • Vlachou E, Ntikoudi A, Govina O, Lavdaniti M, Kotsalas N, Tsartsalis A, Dimitriadis G. 2020. Effects of probiotics on diabetic nephropathy: a systematic review. Curr Clin Pharmacol. 15(3):234–242. doi: 10.2174/1574884715666200303112753.
  • Voidarou C,Antoniadou Μ,Rozos G,Tzora A,Skoufos I,Varzakas T,Lagiou A,Bezirtzoglou E. 2020. Fermentative Foods: Microbiology, Biochemistry, Potential Human Health Benefits and Public Health Issues. Foods. 10(1):69. doi:10.3390/foods10010069.
  • Joint FA., WHO working group. 2002. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food., London, ON, Canada.
  • Wong TY, Gemmy CCM, Larsen M, Sharma S, Rafael S. 2016. Erratum: Diabetic Retinopathy. Nature Reviews: Disease Primers. 2(1):1–17.
  • World Health Organization. 2015. Guideline: sugars intake for adults and children. World HealthOrganization. SEARO Regional office for the South East Asia (RGO), WHO South-East Asia.
  • Xu K-Y, Xia G-H, Lu J-Q, Chen M-X, Zhen X, Wang S, You C, Nie J, Zhou H-W, Yin J. 2017. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 7(1):1445. doi: 10.1038/s41598-017-01387-y.
  • Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Group JDCDMS, Japan Diabetes Clinical Data Management Study Group. 2009. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 24(4):1212–1219. doi: 10.1093/ndt/gfn603.
  • Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X. 2019. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 20:247–260. doi: 10.1016/j.redox.2018.09.025.
  • Zare Javid A, Aminzadeh M, Haghighi-Zadeh MH, Jamalvandi M. 2020. The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. A placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab Syndr Obes. 13:607–617. doi: 10.2147/DMSO.S238867.
  • Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, Yang J, Chen X, Wang H. 2021. Gut microbiota and type 2 diabetes mellitus: association, mechanism, and translational applications. Mediators Inflamm. 2021:5110276–5110212. doi: 10.1155/2021/5110276.
  • Zheng Y, Zhang L, Bonfili L, de Vivo L, Eleuteri AM, Bellesi M. 2023. Probiotics supplementation attenuates inflammation and oxidative stress induced by chronic sleep restriction. Nutrients. 15(6):1518. doi: 10.3390/nu15061518.
  • Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X, Yang R, Jiang R, Xu Y, Qin H. 2018. Dysbiosis signatures of gut microbiota in coronary artery disease. Physiol Genomics. 50(10):893–903. doi: 10.1152/physiolgenomics.00070.2018.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.